E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/8/2008 in the Prospect News Structured Products Daily.

JPMorgan to price 10% reverse exchangeables linked to Merck

By Laura Lutz

Des Moines, April 8 - JPMorgan Chase & Co. plans to price an issue of 10% reverse exchangeable notes due April 30, 2009 linked to the common stock of Merck & Co., Inc., according to an FWP filing with the Securities and Exchange Commission.

Interest will be payable monthly.

If the stock drops below the knock-in price - 75% of the initial share price - during the life of the notes and finishes below its initial price, the payout at maturity will be a number of Merck shares equal to par divided by the initial share price.

Otherwise, the payout will be par.

The notes will price on April 25 and settle on April 30.

J.P. Morgan Securities Inc. will be the agent.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.